Latest News

James Hardie Industries (ASX:JHX) is back in focus after third quarter earnings and sales came in ahead of analyst expectations. Management also lifted full year guidance and reported faster than expected progress on the AZEK integration. See our latest analysis for James Hardie Industries. At a share price of A$36.54, James Hardie has seen a 12.6% 7 day share price return and a 41.7% 90 day share price return, even though the 1 year total shareholder return is a 29% decline. This suggests...

US regulators at the Federal Trade Commission have warned Apple that its Apple News service may breach consumer protection rules by allegedly favoring certain political viewpoints. Separately, Apple is dealing with internal development delays for its AI powered Siri upgrade, affecting key voice features planned for upcoming iOS releases. For investors watching NasdaqGS:AAPL, these twin storylines sit at the intersection of regulation and product development. Apple relies heavily on its...

Earlier this month, American Healthcare REIT, Inc. announced that Chief Executive Officer and President Danny Prosky took a medical leave of absence on February 3, 2026, with Chairman Jeffrey T. Hanson stepping in as Interim CEO and President to work with the senior leadership team on maintaining operations and existing priorities. This leadership change comes as the company highlights its diversified healthcare real estate portfolio and sizeable 2025 acquisitions, underscoring an emphasis...

What ANI Pharmaceuticals’ recent performance means for investors ANI Pharmaceuticals (ANIP) has been drawing attention after a mixed stretch in its share performance, with a gain of 0.9% in the past day contrasted against weaker moves over the past month. See our latest analysis for ANI Pharmaceuticals. That small 1 day share price gain sits against weaker recent momentum, with 7 day, 30 day and 90 day share price returns all in decline. However, the 1 year, 3 year and 5 year total...

Attention on DoorDash (DASH) has picked up ahead of its February 18 earnings report, as investors weigh how order demand, margins, regulatory headlines, and a rich valuation might intersect for the stock. See our latest analysis for DoorDash. The recent pullback, including a 12.1% 7 day share price return and a 24.8% 30 day share price return, shows momentum fading even though DoorDash still carries a premium valuation. Its three year total shareholder return of about 1.6x highlights how...

Compagnie de Saint-Gobain has completed a major expansion at its CertainTeed Roofing facility in Georgia, supporting its manufacturing footprint in the U.S. southeast. The company has also delisted from the London Stock Exchange, concentrating trading in its primary market listings. These moves affect both Saint-Gobain's operational setup in North America and how investors access ENXTPA:SGO shares. Compagnie de Saint-Gobain, traded as ENXTPA:SGO, is currently priced at €90.86, with a 3 year...

RH (NYSE:RH) has introduced its 2026 RH Outdoor Sourcebook, featuring an expanded range of outdoor collections. The company announced the new Sourcebook as a major addition to its outdoor offering, aimed at the upcoming 2026 season. RH, known for its high end home furnishings and design driven collections, continues to build out its brand around whole home concepts that include indoor and outdoor spaces. For investors, a broader outdoor lineup can matter because it ties into consumer...

If you are wondering whether Compass shares still offer value after their recent run, this article will walk through what the current price might be implying about the business. The stock recently closed at US$10.41, with a 7 day return of a 15.2% decline, a 30 day return of a 15.4% decline, a year to date return of a 0.9% decline, and a 1 year return of 31.3%, while the 3 year return is very large. Recent news coverage around Compass has focused on its position within the US real estate...

Kimberly-Clark shareholders have approved the acquisition of Kenvue. The deal brings brands such as Aveeno, Band-Aid, and Tylenol into the Kimberly-Clark portfolio. The transaction positions NasdaqGS:KMB for a broader presence in global health and wellness products. For you as an investor, this vote signals that Kimberly-Clark is committing to a much larger footprint in consumer health, in addition to its existing personal care and tissue business. The shares last closed at $109.41, with a...

Netskope (NTSK) is back in focus after launching its Netskope One Data Lineage tool, aimed at tracking data provenance for AI and compliance, alongside scheduled appearances at upcoming security conferences. See our latest analysis for Netskope. Despite the recent Netskope One Data Lineage launch and upcoming conference presence, Netskope’s share price return has been under pressure, with a 30 day share price return decline of 24.32% and a 90 day share price return decline of 40.16%, pointing...

In recent days, Schneider National announced it has become the first major carrier to surpass 10 million zero-emission miles with its nearly 100 Freightliner eCascadia battery-electric trucks, underscoring its focus on lower-emission freight operations. The milestone, alongside ongoing investments in technology and driver training, highlights how Schneider is using electrification to cut emissions and improve operating efficiency while a major bank’s downgrade raises fresh questions about...

Verizon Communications Inc. recently announced that Sowmyanarayan Sampath will step down as CEO of the Verizon Consumer Group at the end of the first quarter of 2026, with Chief Transformation Officer Alfonso Villanueva taking over on an interim basis as the company cuts 13,000 jobs and shifts 179 corporate-owned stores to franchises. These leadership and organizational changes mark a major step in Verizon’s turnaround plan under new CEO Dan Schulman, aligning consumer operations more...

AGI stock: what the latest move means for investors AGI (AGBK) gained 7.7% in the latest session, drawing attention to the Brazil based financial services provider and its cloud and AI enabled lending and insurance platform serving social security and payroll clients. See our latest analysis for AGI. The 7.7% 1 day share price return lifts AGI to $11.00, while the year to date share price return of 2.3% suggests early momentum that investors may see as a shift in sentiment around its Brazil...

If you are looking at CleanSpark and wondering whether the recent share price makes sense, this article will walk through what that could mean for the stock's current value. The share price closed at US$9.85 most recently, with returns of a 2.3% decline over 7 days, a 26.2% decline over 30 days, a 14.7% decline year to date, a 6.2% decline over 1 year and a very large 3 year gain that compares to a 72.9% decline over 5 years. Recent coverage around CleanSpark has focused on its position as a...

Latest FY 2025 results snapshot Procore Technologies (PCOR) has wrapped up FY 2025 with Q4 revenue of US$349.1 million, a basic EPS loss of US$0.25 per share and net income loss excluding extra items of US$37.6 million. These figures help shape how investors assess its path toward profitability. The company reported quarterly revenue of US$302.0 million in Q4 2024 and US$349.1 million in Q4 2025, while basic EPS shifted from a loss of US$0.42 to a loss of US$0.25 over the same period. This...

Multiple securities class action lawsuits have been filed against Beyond Meat, alleging false and misleading statements about the value of certain long lived assets. Plaintiffs claim the company delayed disclosing a significant non cash impairment charge, which they argue led to losses for investors. The clustered legal actions focus on alleged financial misstatements and delayed regulatory disclosures, raising fresh legal and financial risk for shareholders. For investors watching...

How JDE Peet's is positioned for investors right now JDE Peet's (ENXTAM:JDEP) sits at the center of the global coffee and tea market, and investors are weighing its recent share performance against the company’s current fundamentals and longer term return profile. Over the past month the stock has seen a 0.8% decline, while performance over the past 3 months is slightly positive at 0.3%. Year to date, the move is a 0.8% decline, but the 1 year total return stands at 91.7%, with 3 year and 5...

In February 2026, Entegris reported fourth-quarter 2025 results showing year-on-year declines in sales to US$823.9 million and net income to US$49.4 million, while issuing first-quarter 2026 guidance for net sales of US$785 million to US$825 million and GAAP diluted EPS of US$0.43 to US$0.51. Despite softer recent results, management’s confident outlook, highlighting strong demand for advanced-node materials, ramping capacity in Taiwan and Colorado, and improving free cash flow, points to a...

Recent analyst updates on Sprouts Farmers Market (SFM) have put fresh attention on the stock, as firms including Evercore ISI and Jefferies flagged tougher competition, a choppy consumer backdrop, and lower near term sales and earnings expectations. See our latest analysis for Sprouts Farmers Market. At a share price of US$68.96, Sprouts Farmers Market has seen short term share price pressure, with a 30 day share price return of 15.3% and a 90 day share price return of 15.7%, while the 3 year...

Hercules Capital (HTGC) has drawn fresh attention after reporting fourth quarter and full year 2025 results, highlighting record originations, higher revenue and net income, as well as a new supplemental cash distribution alongside its regular payout. See our latest analysis for Hercules Capital. Despite record originations and the new supplemental cash distribution, Hercules Capital’s recent share price return has been weak, with a 30 day share price return of 17.30% and a year to date share...

If you are wondering whether Boston Scientific's current share price still reflects its long term potential, looking closely at what you are getting for the price you pay can be a useful next step. The stock recently closed at US$74.73, with returns of a 2.0% decline over 7 days, a 20.3% decline over 30 days, a 21.1% decline year to date and a 29.6% decline over 1 year, against longer term returns of 60.6% over 3 years and 96.5% over 5 years. Recent headlines around Boston Scientific have...

If you are wondering whether Euronet Worldwide's current share price properly reflects its underlying business, you are not alone. Many investors are asking the same question right now. The stock last closed at US$67.96, after total shareholder returns of 9.4% decline over 7 days, 9.1% decline over 30 days, 8.3% decline year to date and 35.1% decline over 1 year. These moves sit against a longer backdrop where 3 year returns show a 38.3% decline and 5 year returns show a 54.2% decline. This...

In the past week, IAMGOLD Corporation drew heightened investor attention ahead of its fourth-quarter and full-year results, scheduled for release on 17 February 2026, with the market focused on production and margin guidance across the Côté, Boto, and Essakane assets. Survey-based speculation that IAMGOLD could become a takeover candidate, alongside expectations for progress at Côté and Boto, has added an extra layer of interest to the upcoming earnings update and its implications for the...

Recent performance snapshot Greenbrier Companies (GBX) has drawn attention after a period of strong share price moves, with the stock up about 2% over the past day, 5% over the past week, and 17% over the past month. See our latest analysis for Greenbrier Companies. Recent gains sit on top of a stronger backdrop, with a 90 day share price return of 33.43% and a three year total shareholder return of 111.25%. This points to momentum building despite a flat one year total shareholder return. If...